SAN FRANCISCO, Jan. 10, 2018 /PRNewswire/ -- Blue Mesa Health Inc., a US-based digital therapeutics company with offices
Blue Mesa Health Inc. ("Blue Mesa") launched its digital Diabetes Prevention Program ("DPP") Transform in 2015 to the US enterprise payer market. The program is designed to address the problem of rising chronic disease-related health costs in the US, where one-half of all individuals are either prediabetic or diabetic. Blue Mesa's personalized diabetes prevention program includes digital learning modules, home health monitoring via wireless scales and activity trackers combined with remote health coaching and group social support to guide participants through a year-long program. The goal of the program is for participants to lose 5-7% of their body weight which is correlated with a 58% reduction in progression to type 2 diabetes.
"We launched the Transformemos program in 2017 in a limited fashion to learn how to best meet the needs of individuals whose primary language is Spanish. We have received very positive feedback on our immersive approach," said Blue Mesa Health Inc. CEO Curtis Duggan. "The user experience is completely in Spanish — program enrollment, the digital app, health coaching, the social support group, and the lesson curriculum. We are excited to scale this with health plans within the Solera network, many of which have significant Spanish-speaking populations."
"We are excited to include Transformemos in our network of high-performing DPP providers that allows us to offer a Spanish language solution to our health plan and employer clients," added Brenda Schmidt, CEO of Solera Health. "There is a significant need for a culturally-competent Spanish-language lifestyle change program that effectively meets the needs of diverse populations at-high risk for type 2 diabetes."
According to the CDC, over their lifetime more than 50% of Hispanic adults are expected to develop type 2 diabetes, and Hispanic people are at greater risk for type 2 diabetes than non-Hispanics. Information on the CDC's Prevenga el T2 curriculum is available at https://www.cdc.gov/diabetes/prevention/lifestyle-program/t2/t2materiales.html
About Blue Mesa Health Inc.
Blue Mesa is a digital therapeutics company with headquarters in New York, NY and Vancouver, BC. Blue Mesa provides a digital therapeutics program in the USA and Canada based on the CDC's landmark National Diabetes Prevention Program. In the United States, employers, health plans and accountable care organizations are recognizing the return on investment provided by culturally tailored and digitally delivered preventive health programs. Blue Mesa has raised Series AA funding from Nimbus Synergies Inc., Pallasite Ventures, Stanley Park Ventures Inc., publicly traded technology firm Mobio Technologies Inc. and other US investors. Bluemesahealth.com
About Solera Health Inc.
Solera Health is a personalized prevention network that connects patients, payers, and physicians with a new class of non-clinical healthcare providers, simply and securely. Solera helps consolidate highly fragmented programs and services into one integrated network, allowing health plans and medical providers to increase consumer participation while lowering associated costs. Solera proactively identifies the "best fit" program provider based on each individual's unique needs and preferences, which has proven to have a significant impact on improved patient outcomes at a fraction of the cost of traditional medical care. For more information, please visit: www.soleranetwork.com.
Media Contact Info
View original content:http://www.prnewswire.com/news-releases/solera-health-and-blue-mesa-health-announce-spanish-language-diabetes-prevention-program-partnership-at-jp-morgan-health-care-conference-2018-300580662.html
SOURCE Blue Mesa Health Inc.
Subscribe to our Free Newsletters!
Cyanosis is the bluish or purplish discoloration of the skin and mucus membranes due to lack of ...
Find out about travel shots or vaccination before you travel to your destination country. Travel ...
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...View All